TYP - Tryptamine Therapeutics Limited (ASX) Stock Forum

Tryptamine Therapeutics Limited (ASX:TYP) is an Australian biotechnology company listed on the Australian Securities Exchange (ASX). TYP focuses on the development of innovative therapeutics targeting neurological disorders. Aussie stock traders seeking information and discussions about Tryptamine Therapeutics Limited can find relevant insights and updates on our forum. Join our forum to engage with other traders and stay informed about TYP's developments in the biotechnology sector.